The age of the
mind-machine
is here.
The future of consciousness, tracked daily.
Neurotechnology is rewriting what it means to be human — and what it means to be intelligent. We track the companies, breakthroughs, and ideas at this frontier, so you don't miss a moment of the most important shift in the history of mind.
790+
Companies tracked
across 9 categories
$18B+
VC invested
in the field globally
333+
Articles published
research & industry
Every Sunday
Weekly digest
NeuroTech Digest
"The question is no longer whether machines can think —
but whether they can learn to love."
New
Shop neurotech products
EEG headsets, sleep wearables and brain stimulation devices you can buy today.
Browse by category
View all 790 companies →Featured companies
Kernel
Research Tools
Kernel builds non-invasive neuroimaging helmets — the Flow (TD-fNIRS) and Flux (MEG) systems — designed to make high-resolution brain scanning accessible outside of hospital settings. Founded by Bryan Johnson, the company aims to democratize neuroscience research and brain measurement at scale.
MindMed
Psychedelics
MindMed is a clinical-stage psychedelic medicine company developing novel therapeutics derived from LSD, MDMA, and ibogaine analogs for neurological and psychiatric disorders. Their lead asset MM120 (LSD tartrate) has shown promising Phase 2b results for generalized anxiety disorder.
Recently added
Funding spotlight
Myelin Therapeutics
Series A — $28M
Neural Leap
Seed — $3.5M
Paradox Neurotechnologies
Series B — $42M
CortiSync Neuro
Seed — $8M
MindWave Diagnostics
Series B — $61M
Neurexo Biosciences
Series A — $42M
Latest news
A Neuralink patient with ALS can now control Elon Musk's Grok AI agent and make phone calls using only brain signals.
A new review warns that implanted brain-computer interfaces operate without standardised safety protocols, creating mounting risk as the field accelerates.
Chinese BCI company NeuroXess has closed a 700 million yuan Series B round as its implantable brain-computer interface enters registration clinical trials.
A new review finds brain-computer interface stimulation produces clearer neurological recovery signals in stroke patients than previously understood.
Catalio-backed neuroscience startup Flourish has launched with investment from Bezos Expeditions and Google Ventures.
The FDA has granted De Novo approval to Modius Spero, marking a significant regulatory milestone for wearable neuromodulation in PTSD treatment.
BRYM has raised €650K to develop a wearable neurofeedback platform, signaling continued investor appetite for consumer-grade brain training tech.
A new BCI allows unresponsive ICU patients to control sounds, marking a significant step toward communication for the most critically ill.
Every Sunday
The NeuroTech Digest
Funding rounds, breakthroughs, and top jobs — curated weekly for industry professionals.
Subscribe free →For companies
Reach neurotech decision-makers
Premium listings, newsletter sponsorships, and featured placements.
View packages →News & insights
All articles →
ProductNeuralink Connects to Grok AI Agent, Enabling ALS Patient to Control AI and Make Calls by Thought Alone
A Neuralink patient with ALS can now control Elon Musk's Grok AI agent and make phone calls using only brain signals.
2026-10-30
ResearchImplanted BCIs Still Lack a Shared Safety Rulebook, and the Field Is Running Out of Time to Write One
A new review warns that implanted brain-computer interfaces operate without standardised safety protocols, creating mounting risk as the field accelerates.
2026-10-29
FundingNeuroXess Raises 700 Million Yuan in Series B to Push 'Three-Comprehensive' BCI Into Clinical Trials
Chinese BCI company NeuroXess has closed a 700 million yuan Series B round as its implantable brain-computer interface enters registration clinical trials.
2026-10-28
ResearchBCI Stimulation Shows Stronger Recovery Signal After Stroke, Landmark Review Finds
A new review finds brain-computer interface stimulation produces clearer neurological recovery signals in stroke patients than previously understood.
2026-10-27
FundingFlourish Emerges From Stealth With Bezos and Google Ventures Backing to Tackle Neuroscience
Catalio-backed neuroscience startup Flourish has launched with investment from Bezos Expeditions and Google Ventures.
2026-10-26
ProductFDA Grants De Novo Approval to Modius Spero Neuromodulation Device for PTSD
The FDA has granted De Novo approval to Modius Spero, marking a significant regulatory milestone for wearable neuromodulation in PTSD treatment.
2026-10-25
The field, by the numbers
790+
Companies mapped
across 9 sectors
$18B+
VC invested
in the field globally
3×/week
News published
Mon · Wed · Fri
111+
Articles
research & industry
Companies by sector
28
Brain-Computer
16
Cognitive
29
Mental
44
Neuromodulation
39
Neuropharmaceuticals
27
Neurodiagnostics
11
Research
13
Neurofeedback
39
Psychedelics
The NeuroTech Digest
The signal through the noise — breakthroughs, funding, and ideas at the edge of mind and machine. Curated weekly.
No spam. Unsubscribe anytime.